Financials
- Market Capitalization 2.54 B
- Employee 100
- Founded 2019
- CEO N/A
- Website www.newamsterdampharma.com
- Headquarter Netherlands
- FIGI N/A
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-20.4
Fiyat/satışlar oranı
184.61
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1728 | PGEN Precigen, Inc. - Common Stock | 7.66 USD | -1.92% | -1.67% | +11.66% | +142.41% | 2.74 B USD | ||
| 1774 | BEAM Beam Therapeutics Inc. - Common Stock | 25.13 USD | -2.22% | -6.23% | +4.71% | +1.82% | 2.60 B USD | ||
| 1803 | LQDA Liquidia Corporation - Common Stock | 27.67 USD | +1.06% | -1.00% | -58.57% | +22.43% | 2.48 B USD | ||
| 1822 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 11.93 USD | +2.40% | +2.58% | +9.35% | +490.59% | 2.41 B USD |